• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.硅纳米线诱导人诱导多能干细胞来源的心肌细胞成熟。
Nano Lett. 2015 May 13;15(5):2765-72. doi: 10.1021/nl502227a. Epub 2015 Apr 7.
2
Cell number per spheroid and electrical conductivity of nanowires influence the function of silicon nanowired human cardiac spheroids.每个类球体的细胞数量和纳米线的电导率会影响硅纳米线修饰的人类心脏类球体的功能。
Acta Biomater. 2017 Mar 15;51:495-504. doi: 10.1016/j.actbio.2017.01.029. Epub 2017 Jan 10.
3
Nanowires and Electrical Stimulation Synergistically Improve Functions of hiPSC Cardiac Spheroids.纳米线和电刺激协同改善 hiPSC 心肌球体的功能。
Nano Lett. 2016 Jul 13;16(7):4670-8. doi: 10.1021/acs.nanolett.6b02093. Epub 2016 Jun 23.
4
Myocardial Tissue Engineering With Cells Derived From Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold.利用源自人诱导多能干细胞和类似天然的、高分辨率三维打印支架的细胞进行心肌组织工程
Circ Res. 2017 Apr 14;120(8):1318-1325. doi: 10.1161/CIRCRESAHA.116.310277. Epub 2017 Jan 9.
5
Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.基于人诱导多能干细胞(hiPSC)分化的心肌细胞和心脏细胞外基质构建的工程化心脏组织模型,可用于疾病建模和药物测试应用。
Acta Biomater. 2019 Jul 1;92:145-159. doi: 10.1016/j.actbio.2019.05.016. Epub 2019 May 7.
6
Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells.各向异性微纤维支架增强了诱导多能干细胞来源的心肌细胞的组织性和功能。
Biomater Sci. 2017 Jul 25;5(8):1567-1578. doi: 10.1039/c7bm00323d.
7
Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineering.曲古抑菌素 A 增强人诱导多能干细胞向心肌细胞分化用于心脏组织工程。
Stem Cells Transl Med. 2013 Sep;2(9):715-25. doi: 10.5966/sctm.2012-0161. Epub 2013 Jul 24.
8
Enhanced structural maturation of human induced pluripotent stem cell-derived cardiomyocytes under a controlled microenvironment in a microfluidic system.在微流控系统的受控微环境下,人类诱导多能干细胞衍生的心肌细胞的结构成熟得到增强。
Acta Biomater. 2020 Jan 15;102:273-286. doi: 10.1016/j.actbio.2019.11.044. Epub 2019 Nov 26.
9
Three-Dimensional Adult Cardiac Extracellular Matrix Promotes Maturation of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.三维成人心脏细胞外基质促进人诱导多能干细胞衍生心肌细胞的成熟。
Tissue Eng Part A. 2016 Aug;22(15-16):1016-25. doi: 10.1089/ten.TEA.2016.0027.
10
Cardiac Non-myocyte Cells Show Enhanced Pharmacological Function Suggestive of Contractile Maturity in Stem Cell Derived Cardiomyocyte Microtissues.心脏非心肌细胞在干细胞衍生的心肌细胞微组织中表现出增强的药理功能,提示收缩成熟。
Toxicol Sci. 2016 Jul;152(1):99-112. doi: 10.1093/toxsci/kfw069. Epub 2016 Apr 28.

引用本文的文献

1
Nonclinical Human Cardiac New Approach Methodologies (NAMs) Predict Vanoxerine-Induced Proarrhythmic Potential.非临床人体心脏新方法学(NAMs)预测伐诺昔明致心律失常的可能性。
J Cardiovasc Dev Dis. 2025 Jul 26;12(8):285. doi: 10.3390/jcdd12080285.
2
Harnessing native blueprints for designing bioinks to bioprint functional cardiac tissue.利用天然蓝图设计生物墨水以生物打印功能性心脏组织。
iScience. 2025 Jan 23;28(3):111882. doi: 10.1016/j.isci.2025.111882. eCollection 2025 Mar 21.
3
Human induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) for modeling cardiac arrhythmias: strengths, challenges and potential solutions.用于心律失常建模的人诱导多能干细胞衍生心肌细胞(iPSC-CMs):优势、挑战及潜在解决方案
Front Physiol. 2024 Sep 12;15:1475152. doi: 10.3389/fphys.2024.1475152. eCollection 2024.
4
Advances in cardiac tissue engineering and heart-on-a-chip.心脏组织工程学和芯片上心脏的研究进展。
J Biomed Mater Res A. 2024 Apr;112(4):492-511. doi: 10.1002/jbm.a.37633. Epub 2023 Nov 1.
5
Decellularized heart extracellular matrix alleviates activation of hiPSC-derived cardiac fibroblasts.去细胞化心脏细胞外基质减轻了人诱导多能干细胞衍生的心脏成纤维细胞的激活。
Bioact Mater. 2023 Sep 7;31:463-474. doi: 10.1016/j.bioactmat.2023.08.023. eCollection 2024 Jan.
6
Nanowired human cardiac organoid transplantation enables highly efficient and effective recovery of infarcted hearts.纳米线引导的人心肌类器官移植可实现对梗死心脏的高效且有效的恢复。
Sci Adv. 2023 Aug 4;9(31):eadf2898. doi: 10.1126/sciadv.adf2898.
7
Nanoengineering of gold nanoribbon-embedded isogenic stem cell-derived cardiac organoids.嵌入金纳米带的同基因干细胞衍生心脏类器官的纳米工程。
RSC Adv. 2023 Jun 6;13(25):16985-17000. doi: 10.1039/d3ra01811c. eCollection 2023 Jun 5.
8
Engineering a conduction-consistent cardiac patch with graphene oxide modified butterfly wings and human pluripotent stem cell-derived cardiomyocytes.利用氧化石墨烯修饰的蝴蝶翅膀和人多能干细胞衍生的心肌细胞构建传导一致的心脏补片。
Bioeng Transl Med. 2023 Apr 14;8(3):e10522. doi: 10.1002/btm2.10522. eCollection 2023 May.
9
Brugada Syndrome: Different Experimental Models and the Role of Human Cardiomyocytes From Induced Pluripotent Stem Cells.Brugada 综合征:不同的实验模型和诱导多能干细胞来源的人心肌细胞的作用。
J Am Heart Assoc. 2022 Apr 5;11(7):e024410. doi: 10.1161/JAHA.121.024410. Epub 2022 Mar 24.
10
Functional tissue-engineered microtissue formed by self-aggregation of cells for peripheral nerve regeneration.由细胞自聚集形成的用于周围神经再生的功能性组织工程微组织。
Stem Cell Res Ther. 2022 Jan 10;13(1):3. doi: 10.1186/s13287-021-02676-0.

本文引用的文献

1
Silicon Nanowires: A Review on Aspects of their Growth and their Electrical Properties.硅纳米线:关于其生长及电学性质方面的综述
Adv Mater. 2009 Jul 13;21(25-26):2681-2702. doi: 10.1002/adma.200803754. Epub 2009 Jun 2.
2
In vivo biocompatibility of porous silicon biomaterials for drug delivery to the heart.用于心脏药物输送的多孔硅生物材料的体内生物相容性。
Biomaterials. 2014 Sep;35(29):8394-405. doi: 10.1016/j.biomaterials.2014.05.078. Epub 2014 Jun 28.
3
Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts.人类胚胎干细胞衍生的心肌细胞可使非人类灵长类动物的心脏再生。
Nature. 2014 Jun 12;510(7504):273-7. doi: 10.1038/nature13233. Epub 2014 Apr 30.
4
Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes.工程化的青春期:人多能干细胞来源的心肌细胞的成熟。
Circ Res. 2014 Jan 31;114(3):511-23. doi: 10.1161/CIRCRESAHA.114.300558.
5
Long term stability of nanowire nanoelectronics in physiological environments.纳米线纳米电子学在生理环境中的长期稳定性。
Nano Lett. 2014 Mar 12;14(3):1614-9. doi: 10.1021/nl500070h. Epub 2014 Feb 4.
6
Engineering the heart: evaluation of conductive nanomaterials for improving implant integration and cardiac function.心脏工程:用于改善植入物整合和心脏功能的导电纳米材料评估
Sci Rep. 2014 Jan 16;4:3733. doi: 10.1038/srep03733.
7
The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes.循环拉伸对人胚胎干细胞来源的心肌细胞成熟和 3D 组织形成的影响。
Biomaterials. 2014 Mar;35(9):2798-808. doi: 10.1016/j.biomaterials.2013.12.052. Epub 2014 Jan 11.
8
Lessons from the heart: mirroring electrophysiological characteristics during cardiac development to in vitro differentiation of stem cell derived cardiomyocytes.从心脏中汲取的经验:在心脏发育过程中模拟电生理特征,以体外分化干细胞来源的心肌细胞。
J Mol Cell Cardiol. 2014 Feb;67:12-25. doi: 10.1016/j.yjmcc.2013.12.011. Epub 2013 Dec 23.
9
Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes.生物线:一种用于人类多能干细胞衍生心肌细胞成熟的平台。
Nat Methods. 2013 Aug;10(8):781-7. doi: 10.1038/nmeth.2524. Epub 2013 Jun 23.
10
Carbon nanotubes instruct physiological growth and functionally mature syncytia: nongenetic engineering of cardiac myocytes.碳纳米管指导生理生长和功能成熟的合胞体:心肌细胞的非遗传工程。
ACS Nano. 2013 Jul 23;7(7):5746-56. doi: 10.1021/nn4002193. Epub 2013 Jun 11.

硅纳米线诱导人诱导多能干细胞来源的心肌细胞成熟。

Silicon nanowire-induced maturation of cardiomyocytes derived from human induced pluripotent stem cells.

作者信息

Tan Yu, Richards Dylan, Xu Ruoyu, Stewart-Clark Skylar, Mani Santhosh Kumar, Borg Thomas Keith, Menick Donald R, Tian Bozhi, Mei Ying

机构信息

†Bioengineering Department, Clemson University, Clemson, South Carolina 29634, United States.

‡Department of Chemistry, the James Franck Institute and the Institute for Biophysical Dynamics, University of Chicago, Chicago, Illinois 60637, United States.

出版信息

Nano Lett. 2015 May 13;15(5):2765-72. doi: 10.1021/nl502227a. Epub 2015 Apr 7.

DOI:10.1021/nl502227a
PMID:25826336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4431939/
Abstract

The current inability to derive mature cardiomyocytes from human pluripotent stem cells has been the limiting step for transitioning this powerful technology into clinical therapies. To address this, scaffold-based tissue engineering approaches have been utilized to mimic heart development in vitro and promote maturation of cardiomyocytes derived from human pluripotent stem cells. While scaffolds can provide 3D microenvironments, current scaffolds lack the matched physical/chemical/biological properties of native extracellular environments. On the other hand, scaffold-free, 3D cardiac spheroids (i.e., spherical-shaped microtissues) prepared by seeding cardiomyocytes into agarose microwells were shown to improve cardiac functions. However, cardiomyocytes within the spheroids could not assemble in a controlled manner and led to compromised, unsynchronized contractions. Here, we show, for the first time, that incorporation of a trace amount (i.e., ∼0.004% w/v) of electrically conductive silicon nanowires (e-SiNWs) in otherwise scaffold-free cardiac spheroids can form an electrically conductive network, leading to synchronized and significantly enhanced contraction (i.e., >55% increase in average contraction amplitude), resulting in significantly more advanced cellular structural and contractile maturation.

摘要

目前无法从人类多能干细胞中分化出成熟的心肌细胞,这一直是将这项强大技术转化为临床治疗的限制步骤。为了解决这一问题,基于支架的组织工程方法已被用于在体外模拟心脏发育,并促进源自人类多能干细胞的心肌细胞成熟。虽然支架可以提供三维微环境,但目前的支架缺乏与天然细胞外环境相匹配的物理/化学/生物学特性。另一方面,通过将心肌细胞接种到琼脂糖微孔中制备的无支架三维心脏球体(即球形微组织)显示出可改善心脏功能。然而,球体内的心肌细胞无法以可控方式组装,导致收缩受损且不同步。在此,我们首次表明,在无支架的心脏球体中加入微量(即约0.004% w/v)的导电硅纳米线(e-SiNWs)可形成导电网络,从而实现同步且显著增强的收缩(即平均收缩幅度增加>55%),进而使细胞结构和收缩成熟度显著提高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/3751792ff0db/nihms-684242-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/78deb68285e5/nihms-684242-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/8ad69d7d28e5/nihms-684242-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/028bbfed01ac/nihms-684242-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/4fc19f438fd1/nihms-684242-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/6e4410031d2d/nihms-684242-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/3751792ff0db/nihms-684242-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/78deb68285e5/nihms-684242-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/8ad69d7d28e5/nihms-684242-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/028bbfed01ac/nihms-684242-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/4fc19f438fd1/nihms-684242-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/6e4410031d2d/nihms-684242-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db9e/4431939/3751792ff0db/nihms-684242-f0006.jpg